Quarterly report pursuant to Section 13 or 15(d)

Organization and Description of Business - Summary of Effects of the Adjustment on the Line items Within Consolidated Financial Statements (Detail)

v3.23.1
Organization and Description of Business - Summary of Effects of the Adjustment on the Line items Within Consolidated Financial Statements (Detail) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Dec. 31, 2022
Jan. 01, 2022
Dec. 31, 2021
Error Corrections and Prior Period Adjustments Restatement [Line Items]          
Current liabilities $ 114,263   $ 92,566    
Total Liabilities 303,846   292,478    
Accumulated deficit (1,269,618)   (1,251,023) $ (801,632)  
Total Shareholders' (Deficit) Equity (6,318) $ (32,277) 10,989 (23,639) $ (23,639)
Total Liabilities and Shareholders' (Deficit) Equity 297,528   $ 303,467    
Costs and expenses applicable to revenues (21,241) (20,298)      
Gross profit 15,512 22,492      
Loss from operations (9,327) (9,377)      
Income tax expense 3,799 4,875      
Net (loss) income $ (18,595) $ (10,102)      
Earnings per share $ (0.00) $ (0.06)      
Previously Reported [Member]          
Error Corrections and Prior Period Adjustments Restatement [Line Items]          
Accumulated deficit       (800,390)  
Total Shareholders' (Deficit) Equity       (22,397)  
Revision of Prior Period, Adjustment [Member]          
Error Corrections and Prior Period Adjustments Restatement [Line Items]          
Accumulated deficit       (1,242)  
Total Shareholders' (Deficit) Equity       $ (1,242)